sglt2 inhibitors vs glp 1 Blood Pressure-Lowering Effects of and GLP-1 Receptor Agonists https://link.springer.com/article/10.1007/s11906-025-01342-7 SGLT2 Inhibitors and GLP-1 Receptor

If any of the criteria above cannot be met and you are not satisfied with the product, please reach out anyways and we will evaluate on a case-by-case basis

GLP-1 receptor agonists carry specific long-term risks including increased gastrointestinal adverse events (particularly cholelithiasis and GERD), potential ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers.

GLP-1(936) retained its glucagonostatic effects after genetic/pharmacological inactivation of the GLP-1 receptor

In a letter, the FDA said it needs more data to fully understand several possible risks tied to the drug, including heart and liver problems.

Pharmaceutical giant Pfizer Inc